|
Volumn 2, Issue 1, 1998, Pages 11-13
|
p53 as a biomarker in radiotherapy of carcinoma of the mouth cavity;p53 als Biomarker in der Radiotherapie der Mundhöhlenkarzinome.
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CISPLATIN;
PROTEIN P53;
RADIOSENSITIZING AGENT;
TUMOR MARKER;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
ARTICLE;
BIOPSY;
DRUG EFFECT;
ENZYME IMMUNOASSAY;
HUMAN;
MOUTH MUCOSA;
MOUTH TUMOR;
MULTIMODALITY CANCER THERAPY;
PATHOLOGY;
SQUAMOUS CELL CARCINOMA;
TREATMENT OUTCOME;
BIOPSY;
CARCINOMA, SQUAMOUS CELL;
CHEMOTHERAPY, ADJUVANT;
CISPLATIN;
COMBINED MODALITY THERAPY;
HUMANS;
IMMUNOENZYME TECHNIQUES;
MOUTH MUCOSA;
MOUTH NEOPLASMS;
RADIATION-SENSITIZING AGENTS;
RADIOTHERAPY, ADJUVANT;
TREATMENT OUTCOME;
TUMOR MARKERS, BIOLOGICAL;
TUMOR SUPPRESSOR PROTEIN P53;
MLCS;
MLOWN;
|
EID: 0031601420
PISSN: 14329417
EISSN: None
Source Type: Journal
DOI: 10.1007/s100060050020 Document Type: Article |
Times cited : (2)
|
References (0)
|